Changsen Leng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Changsen Leng has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Diego Arango
Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d’Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
2 shared publications Jeroen Kuipers
UMCG - University Medical Center Groningen
2 shared publications- Sven C. D. van Ijzendoorn
Department of Biomedical Sciences University of Groningen, University Medical Center Groningen Groningen the Netherlands
2 shared publications Albert Gerding
UMCG - University Medical Center Groningen
1 shared publicationArend W Overeem
Department of Biomedical Sciences of Cells and Systems, Section Molecular Cell Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
1 shared publication- Barbara Marleen Bakker
Laboratory of Paediatrics, University Medical Centre Groningen, University of Groningen, The Netherlands
1 shared publication
Latest Publications
- 12 November 2026
- Published by EMBL-EBI
Microvillus inclusion disease-associated MYO5B deficiency impairs endosome-to-mitochondrion iron transfer
BioStudies – one package for all the data supporting a study
- 12 November 2026
- Published by EMBL-EBI
Microvillus inclusion disease-associated MYO5B deficiency impairs endosome-to-mitochondrion iron transfer
BioStudies – one package for all the data supporting a study
- Open Access
- 1 October 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (10)
Modification of Pathological Nodal Classification for pT1b Esophageal Squamous Cell Carcinoma With Lymphovascular Invasion: Over 10‐Year Experience
Background: Lymphovascular invasion (LVI) adversely affects the survival of pT1b esophageal squamous cell carcinoma (ESCC). It is hypothesized that a modified stage classification of pT1b ESCC based on LVI may facilitate multidisciplinary therapy in LVI‐positive patients. Aims: The study aims to investigate the impact of LVI on pathological nodal classification for pT1b ESCC. Methods and Results: Surgically resected pT1b ESCC patients in Sun Yat‐sen University Cancer Center between 2008 and 2018 were retrospectively reviewed. Tumor sections were re‐assessed for LVI by gastrointestinal pathologists. The associations between patient survival and LVI were evaluated by the Log‐rank method. A multivariate Cox regression model was applied to identify the impact of LVI on survival. Prognostic performance was assessed by Harrell's C ‐index. A total of 424 cases with the pT1b stage were included. The risk of LVI was significantly higher in patients with nodal positive status ( p < 0.001) and larger tumor size ( p = 0.033). The 5‐year OS for LVI+ patients were 50.3% versus 78.0% for LVI− ( p < 0.001). Multivariable analyses suggested that LVI ( p = 0.021) and pN ( p = 0.016) stages were two independent adverse prognostic factors in pT1b patients. When classifying LVI+ as an independent subgroup into the pN category, the modified pN staging system demonstrated a superior prognostic performance ( p < 0.001). Conclusion: Tumors with LVI should be defined as a separate subclassification to accurately classify the prognostic category in pT1b patients. Further studies are required to investigate multidisciplinary therapies for LVI+ pT1b patients.
- 1 October 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (10)
Open AccessModification of Pathological Nodal Classification for pT1b Esophageal Squamous Cell Carcinoma With Lymphovascular Invasion: Over 10‐Year Experience
Background: Lymphovascular invasion (LVI) adversely affects the survival of pT1b esophageal squamous cell carcinoma (ESCC). It is hypothesized that a modified stage classification of pT1b ESCC based on LVI may facilitate multidisciplinary therapy in LVI‐positive patients. Aims: The study aims to investigate the impact of LVI on pathological nodal classification for pT1b ESCC. Methods and Results: Surgically resected pT1b ESCC patients in Sun Yat‐sen University Cancer Center between 2008 and 2018 were retrospectively reviewed. Tumor sections were re‐assessed for LVI by gastrointestinal pathologists. The associations between patient survival and LVI were evaluated by the Log‐rank method. A multivariate Cox regression model was applied to identify the impact of LVI on survival. Prognostic performance was assessed by Harrell's C ‐index. A total of 424 cases with the pT1b stage were included. The risk of LVI was significantly higher in patients with nodal positive status ( p < 0.001) and larger tumor size ( p = 0.033). The 5‐year OS for LVI+ patients were 50.3% versus 78.0% for LVI− ( p < 0.001). Multivariable analyses suggested that LVI ( p = 0.021) and pN ( p = 0.016) stages were two independent adverse prognostic factors in pT1b patients. When classifying LVI+ as an independent subgroup into the pN category, the modified pN staging system demonstrated a superior prognostic performance ( p < 0.001). Conclusion: Tumors with LVI should be defined as a separate subclassification to accurately classify the prognostic category in pT1b patients. Further studies are required to investigate multidisciplinary therapies for LVI+ pT1b patients.
- Open Access
- 4 November 2019
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 17 (11) , e3000531
Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation
Recycling endosomes regulate plasma membrane recycling. Recently, recycling endosome–associated proteins have been implicated in the positioning and orientation of the mitotic spindle and cytokinesis. Loss of MYO5B, encoding the recycling endosome–associated myosin Vb, is associated with tumor development and tissue architecture defects in the gastrointestinal tract. Whether loss of MYO5B expression affects mitosis is not known. Here, we demonstrate that loss of MYO5B expression delayed cytokinesis, perturbed mitotic spindle orientation, led to the misorientation of the plane of cell division during the course of mitosis, and resulted in the delamination of epithelial cells. Remarkably, the effects on spindle orientation, but not cytokinesis, were a direct consequence of physical hindrance by giant late endosomes, which were formed in a chloride channel–sensitive manner concomitant with a redistribution of chloride channels from the cell periphery to late endosomes upon loss of MYO5B. Rab7 availability was identified as a limiting factor for the development of giant late endosomes. In accordance, increasing rab7 availability corrected mitotic spindle misorientation and cell delamination in cells lacking MYO5B expression. In conclusion, we identified a novel role for MYO5B in the regulation of late endosome size control and identify the inability to control late endosome size as an unexpected novel mechanism underlying defects in cell division orientation and epithelial architecture.
- 4 November 2019
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 17 (11) , e3000531
Open AccessLoss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation
Recycling endosomes regulate plasma membrane recycling. Recently, recycling endosome–associated proteins have been implicated in the positioning and orientation of the mitotic spindle and cytokinesis. Loss of MYO5B, encoding the recycling endosome–associated myosin Vb, is associated with tumor development and tissue architecture defects in the gastrointestinal tract. Whether loss of MYO5B expression affects mitosis is not known. Here, we demonstrate that loss of MYO5B expression delayed cytokinesis, perturbed mitotic spindle orientation, led to the misorientation of the plane of cell division during the course of mitosis, and resulted in the delamination of epithelial cells. Remarkably, the effects on spindle orientation, but not cytokinesis, were a direct consequence of physical hindrance by giant late endosomes, which were formed in a chloride channel–sensitive manner concomitant with a redistribution of chloride channels from the cell periphery to late endosomes upon loss of MYO5B. Rab7 availability was identified as a limiting factor for the development of giant late endosomes. In accordance, increasing rab7 availability corrected mitotic spindle misorientation and cell delamination in cells lacking MYO5B expression. In conclusion, we identified a novel role for MYO5B in the regulation of late endosome size control and identify the inability to control late endosome size as an unexpected novel mechanism underlying defects in cell division orientation and epithelial architecture.